The rate of NF2 mutations in meningiomas in one large study were found to be 37% in CNS WHO grade 1 cases (81/220), 60% of grade 2 cases (265/441), and 69% of grade 3 tumors (122/176).38 The gene discussed is NF2; the disease is meningioma.